You Searched For "Novavax" and got 19 results
Sort By:
3 mins read
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
2 mins read
Novavax soars 13% after inking deal with UK for 60 million doses of coronavirus vaccine
The UK government will collaborate with Novavax on phase 3 trials of its NVX-CoV2373 vaccine, accor…
Ben Winck
2 mins read
Novavax extends 2-day loss to 31% as the biotech firm delays seeking emergency authorization for its COVID-19 vaccine
"We know that we are delayed from where we thought we would be at this point," Novavax CEO Stanley …
Carla Mozée
2 mins read
Novavax spikes 76% after UK study shows its COVID-19 vaccine is 89% effective
Shares of Novavax soared more than 2,700% since the company advanced the development of its novel C…
Matthew Fox
2 mins read
A biotech investor reportedly made $255 million in just 4 weeks on Novavax's 120% surge
Shares of the pharmaceutical company Novavax have surged nearly 2,300% this year. The company is wo…
Carmen Reinicke
2 mins read
Novavax's COVID-19 vaccine was 89.7% effective in a large trial, and worked against the contagious virus variant first found in the UK
US biotech Novavax said its vaccine was 48.6% effective in a smaller trial in South Africa, where a…
Dr. Catherine Schuster-Bruce
1 min read
Novavax skyrockets 21% after saying its COVID-19 vaccine showed promising results in an early trial
Novavax's COVID-19 vaccine, NVX‑CoV2373, "was generally well-tolerated and elicited robust antibody…
Carmen Reinicke
2 mins read
Novavax's COVID-19 vaccine could be authorized as early as May, its CEO said. A trial suggests it is 89% effective, though slightly less so against contagious variants.
CEO Stanley Erck said Novavax's COVID-19 vaccine could be authorized in the UK first before the FDA…
Grace Dean
1 min read
Novavax surges 15% after it begins phase 3 trial of COVID-19 vaccine
In the scenario that Novavax succeeds in developing a successful COVID-19 vaccine candidate, it is …
Matthew Fox
3 mins read
US-based biotechnology company Novavax’s COVID-19 shot is 90% effective
US-based biotechnology company Novavax's protein-based vaccine has shown overall 90 per cent effica…
2 mins read
Novavax surges 23% after scoring COVID-vaccine supply deal with the EU
EU member states may buy up to 200 million doses of Novavax's vaccine through 2023.
Carla Mozée
1 min read
Novavax leaps 7% after its COVID-19 vaccine won US FDA fast-track authorization
A fast-track would allow Novavax to submit parts of a new drug application, instead of waiting to p…
Shalini Nagarajan
3 mins read
Novavax says its coronavirus vaccine was highly effective in a UK trial, but it didn't work nearly as well against the variant first found in South Africa
The shot was much less effective in a smaller trial in South Africa, where it faced a new variant o…
Lydia Ramsey Pflanzer
2 mins read
Novavax skyrockets 41% after US government grants $1.6 billion for coronavirus vaccine creation
The award is the largest yet from Operation Warp Speed, the Trump administration's plan to develop …
Ben Winck
2 mins read
Novavax climbs 11% after announcing data from UK vaccine trial are expected in early 2021
The biotech firm initially fell in premarket trading as investors focused on a second delay to its …
Ben Winck
2 mins read
Novavax climbs 9% after clinical trial shows the firm's COVID-19 vaccine is 90% effective
The company aims to file for FDA approval of NVX-CoV2373 in the third quarter of 2021 and is contin…
Carla Mozée
1 min read
Novavax surges 12% as its COVID-19 vaccine is found to be 96% effective in preventing the original virus strain
The company said its coronavirus vaccine candidate is 96.4% effective against the original virus st…
Shalini Nagarajan
1 min read
Moderna and Novavax pare losses after Supreme Court strikes down Biden's vaccine mandate for private employers
The vaccine mandate was aimed at private companies with more than 100 employees. The ruling upheld …
Carla Mozée
2 mins read
A new COVID shot is more effective against current variants and may have fewer side effects
The FDA approved an updated COVID-19 vaccine from Novavax. The vaccine is more effective at protect…